First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update

In San Diego on August 12, 2026, First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a biotech company focusing on antibody therapeutics for autoimmune and inflammatory diseases, announced their financial results for the second quarter of 2026 ending on June 30. The company also shared a general business update.